EMA Reviewing Pneumonia Risk With Inhaled Corticosteroids

Drug Industry Daily
A A
The European Medicines Agency is taking a hard look at whether patients taking inhaled corticosteroids for chronic obstructive pulmonary disease are at higher risk for pneumonia.

To View This Article:

Login

Subscribe To Drug Industry Daily